Halozyme Therapeutics expands portfolio with Elektrofi acquisition
Halozyme Therapeutics has successfully completed its acquisition of Elektrofi, broadening its drug delivery capabilities. By incorporating Elektrofi's Hypercon ultra-high concentration ...